Chief Commercial Officer · Gossamer Bio, Inc. · Gossamer Bio, Inc. — Stock Option (Right to Buy)
Side
A
Value
—
Shares
5.80M
Price
—
Executed
Aug 24, 2026
Disclosed
Aug 26, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Aug 24 executedAug 26, 2026 disclosed
GOSS · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Smith Robert Paul JR filed this Form 4 reporting a grant or award of GOSS on Aug 24, 2026. It became public on Aug 26, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Commercial Officer
Smith Robert Paul JRcik:0002003059
Issuer
Gossamer Bio, Inc.cik:0001728117
Revision history · 0
No field has changed since this record was first ingested.
